# A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

> **NCT05590416** · — · RECRUITING · sponsor: **Tianjin Medical University** · enrollment: 15 (estimated)

## Conditions studied

- Vogt-Koyanagi-Harada Disease
- Adalimumab

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT05590416
- **Lead sponsor:** Tianjin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590416, "A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05590416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*